Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 197 articles:
HTML format
Text format



Single Articles


    August 2019
  1. BACKSTROM D, Domellof ME, Forsgren L
    Author response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:279.
    PubMed     Text format    


  2. KELLER DL
    Reader response: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:279.
    PubMed     Text format    


  3. SIEGLER JE 3RD, Galetta S
    Editors' note: Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2019;93:278.
    PubMed     Text format    


  4. SHIN JH, Park KW, Heo KO, Chung SJ, et al
    Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.
    Neurology. 2019 Aug 1. pii: WNL.0000000000008053.
    PubMed     Text format     Abstract available


    July 2019
  5. YOON EJ, Ismail Z, Hanganu A, Kibreab M, et al
    Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.
    Neurology. 2019 Jul 18. pii: WNL.0000000000007968.
    PubMed     Text format     Abstract available


  6. BAIG F, Kelly MJ, Lawton MA, Ruffmann C, et al
    Impulse control disorders in Parkinson and RBD: A longitudinal study of severity.
    Neurology. 2019 Jul 16. pii: WNL.0000000000007942.
    PubMed     Text format     Abstract available


  7. LENKA A, Pagonabarraga J, Pal PK, Bejr-Kasem H, et al
    Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007913.
    PubMed     Text format     Abstract available


  8. LEE MJ, Pak K, Kim JH, Kim YJ, et al
    Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease.
    Neurology. 2019 Jul 9. pii: WNL.0000000000007939.
    PubMed     Text format     Abstract available


  9. BARICHELLA M, Cereda E, Pinelli G, Iorio L, et al
    Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome.
    Neurology. 2019 Jul 5. pii: WNL.0000000000007858.
    PubMed     Text format     Abstract available


    June 2019

  10. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019;92:1166.
    PubMed     Text format    


  11. GERA A, Witek N, Bailey M
    Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease.
    Neurology. 2019;92:1116-1118.
    PubMed     Text format    


    May 2019
  12. HOPFNER F, Wod M, Hoglinger GU, Blaabjerg M, et al
    Use of beta2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
    Neurology. 2019 May 24. pii: WNL.0000000000007694.
    PubMed     Text format     Abstract available


  13. PONTONE GM, Koch G
    An association between bipolar disorder and Parkinson disease: When mood makes you move.
    Neurology. 2019 May 22. pii: WNL.0000000000007641.
    PubMed     Text format    


  14. HUANG MH, Cheng CM, Huang KL, Hsu JW, et al
    Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study.
    Neurology. 2019 May 22. pii: WNL.0000000000007649.
    PubMed     Text format     Abstract available


  15. GIANNINI G, Francois M, Lhommee E, Polosan M, et al
    Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.
    Neurology. 2019 May 17. pii: WNL.0000000000007665.
    PubMed     Text format     Abstract available


  16. DE PABLO-FERNANDEZ E, Warner T
    Author response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:925-926.
    PubMed     Text format    


  17. LAI SW
    Reader response: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:925.
    PubMed     Text format    


  18. GANESH A, Galetta S
    Editors' note: Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2019;92:924.
    PubMed     Text format    


  19. LAU B, Meier N, Serra G, Czernecki V, et al
    Axial symptoms predict mortality in patients with Parkinson disease with subthalamic stimulation.
    Neurology. 2019 May 1. pii: WNL.0000000000007562.
    PubMed     Text format     Abstract available


    April 2019

  20. Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:871.
    PubMed     Text format    


  21. KLEPITSKAYA O
    Author response: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:869.
    PubMed     Text format    


  22. MARQUES AR, Fantini ML, Durif F
    Reader response: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:868-869.
    PubMed     Text format    


  23. GANESH A, Galetta S
    Editors' note: Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2019;92:868.
    PubMed     Text format    


  24. TUCK KK, Tarolli CG
    Palliative care and advance care planning in Parkinson disease.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007555.
    PubMed     Text format    


  25. NARENDRA DP, Isonaka R, Nguyen D, Schindler AB, et al
    Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007614.
    PubMed     Text format    


  26. LUM HD, Jordan SR, Brungardt A, Ayele R, et al
    Framing advance care planning in Parkinson disease: Patient and care partner perspectives.
    Neurology. 2019 Apr 26. pii: WNL.0000000000007552.
    PubMed     Text format     Abstract available


  27. FORREST SL, Crockford DR, Sizemova A, McCann H, et al
    Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.
    Neurology. 2019 Apr 24. pii: WNL.0000000000007530.
    PubMed     Text format     Abstract available


  28. BOUGEA A, Maraki MI, Yannakoulia M, Stamelou M, et al
    Higher probability of prodromal Parkinson disease is related to lower cognitive performance.
    Neurology. 2019 Apr 3. pii: WNL.0000000000007453.
    PubMed     Text format     Abstract available


    March 2019
  29. CONNOR KI, Cheng EM, Barry F, Siebens HC, et al
    Randomized trial of care management to improve Parkinson disease care quality.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007324.
    PubMed     Text format     Abstract available


  30. CALABRESI P, Nigro P, Schwarz HB
    A nurse-led model increases quality of care in Parkinson disease.
    Neurology. 2019 Mar 22. pii: WNL.0000000000007295.
    PubMed     Text format    


  31. BUCHMAN AS, Yu L, Wilson RS, Leurgans SE, et al
    Progressive parkinsonism in older adults is related to the burden of mixed brain pathologies.
    Neurology. 2019 Mar 20. pii: WNL.0000000000007315.
    PubMed     Text format     Abstract available


  32. METZER WS, Rodrigues FB
    Managing treatment fluctuations in Parkinson disease: "On" again-, "off" again.
    Neurology. 2019 Mar 1. pii: WNL.0000000000007193.
    PubMed     Text format    


    February 2019
  33. AKHTAR RS, Mano T
    High serum neurofilament light chain predicts a worse fate in early parkinsonism.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007194.
    PubMed     Text format    


  34. MARQUES TM, van Rumund A, Oeckl P, Kuiperij HB, et al
    Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
    Neurology. 2019 Feb 27. pii: WNL.0000000000007179.
    PubMed     Text format     Abstract available


  35. CHUNG SJ, Bae YJ, Jun S, Yoo HS, et al
    Dysautonomia is associated with structural and functional alterations in Parkinson disease.
    Neurology. 2019 Feb 22. pii: WNL.0000000000007181.
    PubMed     Text format     Abstract available


  36. VIDENOVIC A, Messinis L
    Enlightened PD: A novel treatment for Parkinson disease?
    Neurology. 2019 Feb 15. pii: WNL.0000000000007078.
    PubMed     Text format    


  37. RUTTEN S, Vriend C, Smit JH, Berendse HW, et al
    Bright light therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2019 Feb 15. pii: WNL.0000000000007090.
    PubMed     Text format     Abstract available


  38. ESPAY AJ, Vizcarra JA, Marsili L, Lang AE, et al
    Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
    Neurology. 2019;92:329-337.
    PubMed     Text format     Abstract available


  39. CHEN CC
    Is outcome of subthalamic nucleus deep brain stimulation in Parkinson disease predictable?
    Neurology. 2019 Feb 8. pii: WNL.0000000000007023.
    PubMed     Text format    


  40. SCHUEPBACH WMM, Tonder L, Schnitzler A, Krack P, et al
    Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
    Neurology. 2019 Feb 8. pii: WNL.0000000000007037.
    PubMed     Text format     Abstract available


    December 2018
  41. PRANGE S, Danaila T, Laurencin C, Caire C, et al
    Age and time course of long-term motor and nonmotor complications in Parkinson disease.
    Neurology. 2018 Dec 12. pii: WNL.0000000000006737.
    PubMed     Text format     Abstract available


    November 2018
  42. JUTTUKONDA MR, Franco G, Englot DJ, Lin YC, et al
    White matter differences between essential tremor and Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006694.
    PubMed     Text format     Abstract available


  43. KIM R, Lee J, Kim HJ, Kim A, et al
    CSF beta-amyloid42 and risk of freezing of gait in early Parkinson disease.
    Neurology. 2018 Nov 30. pii: WNL.0000000000006692.
    PubMed     Text format     Abstract available


  44. KARCESKI S
    Parkinson disease and mortality: Understanding how the two are connected.
    Neurology. 2018;91:e2106-e2108.
    PubMed     Text format    


  45. KOO BB
    Author response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1030.
    PubMed     Text format    


  46. BRUNO V, Mancini D, Zurowski M, Miyasaki JM, et al
    Reader response: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed     Text format    


  47. GANESH A, Galetta S
    Editors' note: Demoralization in Parkinson disease.
    Neurology. 2018;91:1029.
    PubMed     Text format    


  48. BLEDSOE IO, Stebbins GT, Merkitch D, Goldman JG, et al
    White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Neurology. 2018 Nov 14. pii: WNL.0000000000006646.
    PubMed     Text format     Abstract available


  49. TURCANO P, Mielke MM, Bower JH, Parisi JE, et al
    Levodopa-induced dyskinesia in Parkinson disease: A population-based cohort study.
    Neurology. 2018 Nov 7. pii: WNL.0000000000006643.
    PubMed     Text format     Abstract available


    October 2018
  50. GOLBE LI, Leyton CE
    Life expectancy in Parkinson disease.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006560.
    PubMed     Text format    


  51. BACKSTROM D, Granasen G, Domellof ME, Linder J, et al
    Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
    Neurology. 2018 Oct 31. pii: WNL.0000000000006576.
    PubMed     Text format     Abstract available


  52. FERRAYE MU
    Author response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:811.
    PubMed     Text format    


  53. VAN GERPEN JA, Tipton PW, Uitti RJ
    Reader response: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810-811.
    PubMed     Text format    


  54. KARAM C, Galetta S
    Editors' note: The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2018;91:810.
    PubMed     Text format    


  55. HELMICH RC, Hallett M, Dirkx MF
    Author response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:724.
    PubMed     Text format    


  56. JANKOVIC J
    Reader response: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:723.
    PubMed     Text format    


  57. KARAM C, Galetta S
    Editors' note: The nature of postural tremor in Parkinson disease.
    Neurology. 2018;91:722.
    PubMed     Text format    


  58. GERAEDTS VJ, Boon LI, Marinus J, Gouw AA, et al
    Clinical correlates of quantitative EEG in Parkinson disease: A systematic review.
    Neurology. 2018 Oct 5. pii: WNL.0000000000006473.
    PubMed     Text format     Abstract available


    September 2018
  59. MORENO GM, Gandhi R, Lessig SL, Wright B, et al
    Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Neurology. 2018 Sep 26. pii: WNL.0000000000006396.
    PubMed     Text format    


    August 2018
  60. SPERLING SA, Shah BB, Barrett MJ, Bond AE, et al
    Focused ultrasound thalamotomy in Parkinson disease: Nonmotor outcomes and quality of life.
    Neurology. 2018 Aug 29. pii: WNL.0000000000006279.
    PubMed     Text format     Abstract available


  61. ADAMS JL, La Morgia C
    The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006148.
    PubMed     Text format    


  62. AHN J, Lee JY, Kim TW, Yoon EJ, et al
    Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006157.
    PubMed     Text format     Abstract available


  63. KLEPITSKAYA O, Liu Y, Sharma S, Sillau SH, et al
    Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
    Neurology. 2018 Aug 15. pii: WNL.0000000000006162.
    PubMed     Text format     Abstract available


  64. PAGANO G, De Micco R, Yousaf T, Wilson H, et al
    REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Neurology. 2018 Aug 8. pii: WNL.0000000000006134.
    PubMed     Text format     Abstract available


  65. MACLEOD AD, Myint PK, Counsell CE
    Author response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:287.
    PubMed     Text format    


  66. MARINELLI L
    Reader response: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed     Text format    


  67. ALCAUSKAS M, Galetta S
    Editors' note: Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2018;91:286.
    PubMed     Text format    


  68. THOMPSON T, Poulter D, Miles C, Solmi M, et al
    Driving impairment and crash risk in Parkinson disease: A systematic review and meta-analysis.
    Neurology. 2018 Aug 3. pii: WNL.0000000000006132.
    PubMed     Text format     Abstract available


    July 2018
  69. KARCESKI S
    Does deep brain stimulation help early or mild Parkinson disease?
    Neurology. 2018;91:e495-e497.
    PubMed     Text format    


  70. BRODSKY MA
    Author response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:241-242.
    PubMed     Text format    


  71. TROSTER AI
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240-241.
    PubMed     Text format    


  72. AZIZ TZ
    Editorialist response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:240.
    PubMed     Text format    


  73. SIDIROPOULOS C
    Reader response: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239-240.
    PubMed     Text format    


  74. KARAM C, Galetta S
    Editors' note: Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2018;91:239.
    PubMed     Text format    


  75. FERRER P
    Author response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:192.
    PubMed     Text format    


  76. BHATTACHARJEE S
    Reader response: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191-192.
    PubMed     Text format    


  77. ALCAUSKAS M, Galetta S
    Editors' note: Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2018;91:191.
    PubMed     Text format    


  78. FIRBANK MJ, Parikh J, Murphy N, Killen A, et al
    Reduced occipital GABA in Parkinson disease with visual hallucinations.
    Neurology. 2018 Jul 18. pii: WNL.0000000000006007.
    PubMed     Text format     Abstract available


  79. ONOFRJ M, Gilbert GJ
    GABA and hallucinations in Parkinson disease: Who is that sitting on my chair?
    Neurology. 2018 Jul 18. pii: WNL.0000000000005985.
    PubMed     Text format    


  80. SEARLES NIELSEN S, Racette BA
    Author response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed     Text format    


  81. KAWADA T
    Reader response: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:104.
    PubMed     Text format    


  82. ALCAUSKAS M, Galetta S
    Editors' note: A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2018;91:103.
    PubMed     Text format    


  83. NONNEKES J, Bloem BR
    Deliberate gait scissoring to overcome freezing of gait in Parkinson disease.
    Neurology. 2018;91:97.
    PubMed     Text format    


    June 2018
  84. HACKER ML, DeLong MR, Turchan M, Heusinkveld LE, et al
    Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Neurology. 2018 Jun 29. pii: WNL.0000000000005903.
    PubMed     Text format     Abstract available


  85. CORVOL JC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Longitudinal analysis of impulse control disorders in Parkinson disease.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005816.
    PubMed     Text format     Abstract available


  86. DE PABLO-FERNANDEZ E, Goldacre R, Pakpoor J, Noyce AJ, et al
    Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
    Neurology. 2018 Jun 13. pii: WNL.0000000000005771.
    PubMed     Text format     Abstract available


    May 2018
  87. CHEN H
    Author response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:941.
    PubMed     Text format    


  88. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Reader response: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed     Text format    


  89. ALCAUSKAS M, Galetta S
    Editors' note: Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2018;90:940.
    PubMed     Text format    


  90. BOOT E, Butcher NJ, Udow S, Marras C, et al
    Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.
    Neurology. 2018 May 11. pii: WNL.0000000000005660.
    PubMed     Text format     Abstract available


  91. GROSS A, Racette BA, Camacho-Soto A, Dube U, et al
    Use of medical care biases associations between Parkinson disease and other medical conditions.
    Neurology. 2018 May 9. pii: WNL.0000000000005678.
    PubMed     Text format     Abstract available


  92. PALMA JA, Mano T
    Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter?
    Neurology. 2018 May 4. pii: WNL.0000000000005624.
    PubMed     Text format    


    April 2018
  93. FERREIRA JJ, Lees AJ, Poewe W, Rascol O, et al
    Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease.
    Neurology. 2018 Apr 25. pii: WNL.0000000000005557.
    PubMed     Text format     Abstract available


  94. FULLARD ME, Willis AW
    Author response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:813.
    PubMed     Text format    


  95. BRYANT MS, Protas EJ
    Reader response: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed     Text format    


  96. KARAM C, Galetta S
    Editors' note: Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2018;90:812.
    PubMed     Text format    


  97. GARDNER RC, Byers AL, Barnes DE, Li Y, et al
    Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study.
    Neurology. 2018 Apr 18. pii: WNL.0000000000005522.
    PubMed     Text format     Abstract available


  98. ROOS E, Grotta A, Yang F, Bellocco R, et al
    Body mass index, sitting time, and risk of Parkinson disease.
    Neurology. 2018;90:e1413-e1417.
    PubMed     Text format     Abstract available


  99. KIM IY, O'Reilly EJ, Hughes KC, Gao X, et al
    Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.
    Neurology. 2018 Apr 11. pii: WNL.0000000000005473.
    PubMed     Text format     Abstract available


  100. PAGANO G, Polychronis S, Wilson H, Giordano B, et al
    Diabetes mellitus and Parkinson disease.
    Neurology. 2018 Apr 6. pii: WNL.0000000000005475.
    PubMed     Text format     Abstract available


  101. DAS RR, Unger MM
    Diabetes and Parkinson disease: A sweet spot?
    Neurology. 2018 Apr 6. pii: WNL.0000000000005470.
    PubMed     Text format    


  102. BARRETT MJ, Blair JC, Sperling SA, Smolkin ME, et al
    Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005421.
    PubMed     Text format     Abstract available


  103. KOO BB, Chow CA, Shah DR, Khan FH, et al
    Demoralization in Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005425.
    PubMed     Text format     Abstract available


  104. BOHNEN NI, Teipel SJ
    Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005408.
    PubMed     Text format    


    March 2018
  105. BOLLAND MJ, Avenell A, Gamble G, Grey A, et al
    Reader response: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to
    Neurology. 2018;90:627-628.
    PubMed     Text format    


  106. KARAM C, Galetta S
    Editors' note: Expression of Concern: Does compensatory hyperparathyroidism predispose to ischemic stroke? Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy; An alternative to vitamin D supplementation to p
    Neurology. 2018;90:627.
    PubMed     Text format    


  107. ROY HA, Aziz TZ, Fitzgerald JJ, Green AL, et al
    Beta oscillations and urinary voiding in Parkinson disease.
    Neurology. 2018 Mar 23. pii: WNL.0000000000005355.
    PubMed     Text format     Abstract available


  108. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed     Text format    


  109. BRODSKY M, Lahna D, Pollock J, Pettersson D, et al
    Nigrosome 1 absence in de novo Parkinson disease.
    Neurology. 2018;90:522-523.
    PubMed     Text format    


    February 2018
  110. DIRKX MF, Zach H, Bloem BR, Hallett M, et al
    The nature of postural tremor in Parkinson disease.
    Neurology. 2018 Feb 23. pii: WNL.0000000000005215.
    PubMed     Text format     Abstract available


  111. HASSAN A
    No handshake agreement on postural tremor subtypes in Parkinson disease?
    Neurology. 2018 Feb 23. pii: WNL.0000000000005199.
    PubMed     Text format    


  112. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
    Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
    PubMed     Text format     Abstract available


  113. WEISS D, Massano J
    Approaching adaptive control in neurostimulation for Parkinson disease: Autopilot on.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005111.
    PubMed     Text format    


  114. ARLOTTI M, Marceglia S, Foffani G, Volkmann J, et al
    Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
    Neurology. 2018 Feb 14. pii: WNL.0000000000005121.
    PubMed     Text format     Abstract available


  115. HONMA M, Masaoka Y, Kuroda T, Futamura A, et al
    Impairment of cross-modality of vision and olfaction in Parkinson disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005110.
    PubMed     Text format     Abstract available


    January 2018
  116. MURATA M, Odawara T, Hasegawa K, Iiyama S, et al
    Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005010.
    PubMed     Text format     Abstract available


  117. HERSHEY LA, Irwin DJ
    Zonisamide for DLB parkinsonism: An old drug used in a new context.
    Neurology. 2018 Jan 24. pii: WNL.0000000000005006.
    PubMed     Text format    


  118. LEE PC, Ahmed I, Loriot MA, Mulot C, et al
    Smoking and Parkinson disease: Evidence for gene-by-smoking interactions.
    Neurology. 2018 Jan 19. pii: WNL.0000000000004953.
    PubMed     Text format     Abstract available


  119. DAVIS JL, Kurek JA, Morgan JC, Sethi KD, et al
    Teaching Video NeuroImages: Oculogyric crisis in treated Parkinson disease.
    Neurology. 2018;90:e263.
    PubMed     Text format    


  120. MUNOZ DG, Fujioka S
    Caffeine and Parkinson disease: A possible diagnostic and pathogenic breakthrough.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004898.
    PubMed     Text format    


  121. FUJIMAKI M, Saiki S, Li Y, Kaga N, et al
    Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
    Neurology. 2018 Jan 3. pii: WNL.0000000000004888.
    PubMed     Text format     Abstract available


    December 2017
  122. BARTHEL C, Nonnekes J, van Helvert M, Haan R, et al
    The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2017 Dec 20. pii: WNL.0000000000004795.
    PubMed     Text format     Abstract available


  123. ROSSO AL, Bohnen NI, Launer LJ, Aizenstein HJ, et al
    Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004842.
    PubMed     Text format     Abstract available


  124. MELE B, Holroyd-Leduc J, Smith EE, Pringsheim T, et al
    Detecting anxiety in individuals with Parkinson disease: A systematic review.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004771.
    PubMed     Text format     Abstract available


  125. FERRER P, Montoya J, Garcia Ruiz PJ
    Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.
    Neurology. 2017;89:e272-e273.
    PubMed     Text format    


  126. BROCKMANN K, Lerche S, Dilger SS, Stirnkorb JG, et al
    SNPs in Abeta clearance proteins: Lower CSF Abeta1-42 levels and earlier onset of dementia in PD.
    Neurology. 2017;89:2335-2340.
    PubMed     Text format     Abstract available


  127. DAHODWALA N, Shah K, He Y, Wu SS, et al
    Sex disparities in access to caregiving in Parkinson disease.
    Neurology. 2017 Dec 1. pii: WNL.0000000000004764.
    PubMed     Text format     Abstract available


    November 2017
  128. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Author response: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  129. GUARALDI P, Poda R, Calandra-Buonaura G, Solieri L, et al
    Letter re: Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2017;89:2122.
    PubMed     Text format    


  130. DODEL R
    beta-Amyloid pathology and Parkinson disease.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004756.
    PubMed     Text format    


  131. WHITWELL JL, Weigand SD, Duffy JR, Clark HM, et al
    Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech.
    Neurology. 2017 Nov 1. pii: 10.1212/WNL.0000000000004685.
    PubMed     Text format     Abstract available


    October 2017
  132. CUMMING K, Macleod AD, Myint PK, Counsell CE, et al
    Early weight loss in parkinsonism predicts poor outcomes: Evidence from an incident cohort study.
    Neurology. 2017 Oct 27. pii: 10.1212/WNL.0000000000004691.
    PubMed     Text format     Abstract available


  133. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Text format     Abstract available


  134. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Text format     Abstract available


  135. TABUAS-PEREIRA M, Santana I, Santo GC
    Clinical Reasoning: A 55-year-old man with rapidly progressive dementia and parkinsonism.
    Neurology. 2017;89:e182-e187.
    PubMed     Text format    


  136. BRODSKY MA, Anderson S, Murchison C, Seier M, et al
    Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease.
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004630.
    PubMed     Text format     Abstract available


  137. AZIZ TZ, Hariz M
    To sleep or not to sleep during deep brain stimulation surgery for Parkinson disease?
    Neurology. 2017 Oct 6. pii: 10.1212/WNL.0000000000004635.
    PubMed     Text format    


    September 2017
  138. LEEHEY M, Luo S, Sharma S, Wills AA, et al
    Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004572.
    PubMed     Text format     Abstract available


  139. HEDERA P, Davis TL
    Can lifestyle modification slow progression of Parkinson disease?
    Neurology. 2017 Sep 29. pii: 10.1212/WNL.0000000000004580.
    PubMed     Text format    


  140. POSTUMA RB, Anang J, Pelletier A, Joseph L, et al
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.
    PubMed     Text format     Abstract available


  141. MOREAU C, Barton BR, Devos D
    Virtually reducing fall risk in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004581.
    PubMed     Text format    


  142. MAIDAN I, Rosenberg-Katz K, Jacob Y, Giladi N, et al
    Disparate effects of training on brain activation in Parkinson disease.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004576.
    PubMed     Text format     Abstract available


  143. THORMANN A, Sorensen PS, Koch-Henriksen N, Laursen B, et al
    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality.
    Neurology. 2017 Sep 20. pii: 10.1212/WNL.0000000000004508.
    PubMed     Text format     Abstract available


  144. SHAMIR R, Klein C, Amar D, Vollstedt EJ, et al
    Analysis of blood-based gene expression in idiopathic Parkinson disease.
    Neurology. 2017 Sep 15. pii: 10.1212/WNL.0000000000004516.
    PubMed     Text format     Abstract available


  145. LECLAIR-VISONNEAU L, Clairembault T, Coron E, Le Dily S, et al
    REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.
    Neurology. 2017 Sep 8. pii: 10.1212/WNL.0000000000004496.
    PubMed     Text format     Abstract available


  146. BOWMAN GL
    Biomarkers for early detection of Parkinson disease: A scent of consistency with olfactory dysfunction.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004383.
    PubMed     Text format    


  147. CHEN H, Shrestha S, Huang X, Jain S, et al
    Olfaction and incident Parkinson disease in US white and black older adults.
    Neurology. 2017 Sep 6. pii: 10.1212/WNL.0000000000004382.
    PubMed     Text format     Abstract available


  148. SEARLES NIELSEN S, Warden MN, Camacho-Soto A, Willis AW, et al
    A predictive model to identify Parkinson disease from administrative claims data.
    Neurology. 2017 Sep 1. pii: 10.1212/WNL.0000000000004536.
    PubMed     Text format     Abstract available


    August 2017
  149. FULLARD ME, Thibault DP, Hill A, Fox J, et al
    Utilization of rehabilitation therapy services in Parkinson disease in the United States.
    Neurology. 2017 Aug 23. pii: 10.1212/WNL.0000000000004355.
    PubMed     Text format     Abstract available


  150. NOLANO M, Provitera V, Manganelli F, Iodice R, et al
    Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients.
    Neurology. 2017;89:776-784.
    PubMed     Text format     Abstract available


  151. SHPRECHER DR, Majersik JJ
    The virtual house call: A 21st-century innovation in the care of patients with Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004366.
    PubMed     Text format    


  152. BECK CA, Beran DB, Biglan KM, Boyd CM, et al
    National randomized controlled trial of virtual house calls for Parkinson disease.
    Neurology. 2017 Aug 16. pii: 10.1212/WNL.0000000000004357.
    PubMed     Text format     Abstract available


  153. VERHAGEN METMAN L, Espay AJ
    Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.
    Neurology. 2017;89:e83-e84.
    PubMed     Text format    


  154. CURY RG, Fraix V, Castrioto A, Perez Fernandez MA, et al
    Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.
    Neurology. 2017 Aug 2. pii: 10.1212/WNL.0000000000004295.
    PubMed     Text format     Abstract available


    July 2017
  155. REGENSBURGER M, Turk M, Pagenstecher A, Schroder R, et al
    VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004240.
    PubMed     Text format    


  156. IRANZO A, Stefani A, Serradell M, Marti MJ, et al
    Characterization of patients with longstanding idiopathic REM sleep behavior disorder.
    Neurology. 2017;89:242-248.
    PubMed     Text format     Abstract available


  157. JACOVA C, Factor SA
    Phosphodiesterase 4: Rethinking cognition in Parkinson disease.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004221.
    PubMed     Text format    


  158. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  159. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


  160. CILIA R, Laguna J, Cassani E, Cereda E, et al
    Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004175.
    PubMed     Text format     Abstract available



  161. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017;89:107.
    PubMed     Text format    


    June 2017
  162. HUGHES KC, Gao X, Kim IY, Wang M, et al
    Intake of dairy foods and risk of Parkinson disease.
    Neurology. 2017 Jun 8. pii: 10.1212/WNL.0000000000004057.
    PubMed     Text format     Abstract available


  163. RAJPUT AH, Rajput ML, Ferguson LW, Rajput A, et al
    Baseline motor findings and Parkinson disease prognostic subtypes.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004078.
    PubMed     Text format     Abstract available


    May 2017
  164. MARKOVIC V, Agosta F, Canu E, Inuggi A, et al
    Role of habenula and amygdala dysfunction in Parkinson disease patients with punding.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004012.
    PubMed     Text format     Abstract available


  165. STOCCHI F, Rascol O, Hauser RA, Huyck S, et al
    Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease.
    Neurology. 2017 May 10. pii: 10.1212/WNL.0000000000004003.
    PubMed     Text format     Abstract available


    April 2017
  166. LIU B, Fang F, Pedersen NL, Tillander A, et al
    Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003961.
    PubMed     Text format     Abstract available


  167. BORGHAMMER P, Hamani C
    Preventing Parkinson disease by vagotomy: Fact or fiction?
    Neurology. 2017 Apr 26. pii: 10.1212/WNL.0000000000003969.
    PubMed     Text format    


    March 2017
  168. PAKPOOR J, Noyce A, Goldacre R, Selkihova M, et al
    Viral hepatitis and Parkinson disease: A national record-linkage study.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003848.
    PubMed     Text format     Abstract available


  169. BENITO-LEON J
    Viral hepatitis and the risk of Parkinson disease.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003853.
    PubMed     Text format    


  170. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Text format     Abstract available


  171. SINGER W, Berini SE, Sandroni P, Fealey RD, et al
    Pure autonomic failure: Predictors of conversion to clinical CNS involvement.
    Neurology. 2017;88:1129-1136.
    PubMed     Text format     Abstract available


  172. NONNEKES J, Janssen S, Bloem BR
    Superficial brain stimulation to overcome freezing of gait in Parkinson disease.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003859.
    PubMed     Text format    


  173. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


    February 2017
  174. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  175. BOHNEN NI, Muller M
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:920.
    PubMed     Text format    


  176. BUCHMAN AS, Bennett DA
    Author response: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919-920.
    PubMed     Text format    


  177. MAHLKNECHT P, Kiechl S, Willeit J, Poewe W, et al
    Letter re: Incident parkinsonism in older adults without Parkinson disease.
    Neurology. 2017;88:919.
    PubMed     Text format    


  178. GOLDMAN JG, Bledsoe IO, Merkitch D, Dinh V, et al
    Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003764.
    PubMed     Text format     Abstract available


  179. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Text format     Abstract available


  180. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Text format     Abstract available


  181. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed     Text format    


  182. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Text format     Abstract available


    January 2017
  183. EWENCZYK C, Mesmoudi S, Gallea C, Welter ML, et al
    Antisaccades in Parkinson disease: A new marker of postural control?
    Neurology. 2017 Jan 27. pii: 10.1212/WNL.0000000000003658.
    PubMed     Text format     Abstract available


  184. PEDERSEN KF, Larsen JP, Tysnes OB, Alves G, et al
    Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Neurology. 2017 Jan 20. pii: 10.1212/WNL.0000000000003634.
    PubMed     Text format     Abstract available


  185. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


  186. KUBU CS, Cooper SE, Machado A, Frazier T, et al
    Insights gleaned by measuring patients' stated goals for DBS: More than tremor.
    Neurology. 2017;88:124-130.
    PubMed     Text format     Abstract available


    December 2016
  187. RACETTE BA, Searles Nielsen S, Criswell SR, Sheppard L, et al
    Dose-dependent progression of parkinsonism in manganese-exposed welders.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003533.
    PubMed     Text format     Abstract available


  188. RATNER MH, Fitzgerald E
    Understanding of the role of manganese in parkinsonism and Parkinson disease.
    Neurology. 2016 Dec 28. pii: 10.1212/WNL.0000000000003543.
    PubMed     Text format    


  189. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Text format     Abstract available


    November 2016
  190. CENTI J, Freeman R, Gibbons CH, Neargarder S, et al
    Effects of orthostatic hypotension on cognition in Parkinson disease.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003452.
    PubMed     Text format     Abstract available


  191. BOYLAN LS, Messinis L
    Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003468.
    PubMed     Text format    


  192. MANO T, Britton Z, Britton T
    Anatomo-functional basis of nonmotor symptoms in Parkinson disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003443.
    PubMed     Text format    


  193. PYATIGORSKAYA N, Mongin M, Valabregue R, Yahia-Cherif L, et al
    Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease.
    Neurology. 2016 Nov 11. pii: 10.1212/WNL.0000000000003426.
    PubMed     Text format     Abstract available


  194. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  195. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


  196. BRYS M, Fox MD, Agarwal S, Biagioni M, et al
    Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003279.
    PubMed     Text format     Abstract available


    September 2016
  197. UMEMOTO G, Fujioka S, Yanamoto S, Fukae J, et al
    A case of sudden deterioration in Parkinson disease.
    Neurology. 2016;87:1422.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: